Can Roseola Occur in Adults?
Yes, roseola (exanthem subitum) can occur in adults, though it is rare, with primary HHV-6 infection in adults typically presenting as a mononucleosis-like illness rather than the classic childhood rash pattern 1.
Primary Infection in Adults
While roseola is predominantly a disease of infancy (6 months to 3 years of age), adults can experience primary HHV-6 infection if they escaped childhood exposure. When this occurs:
- The presentation differs from children: Adults typically develop a mononucleosis-like syndrome rather than the classic fever-then-rash pattern 1
- Severe manifestations are possible: Primary infection can rarely cause encephalitis in adults 1
- Documented case in pregnancy: At least one case report describes classic roseola presentation (high fever followed by morbilliform rash) in a pregnant woman 2
Reactivation Disease in Adults
The more clinically relevant concern in adults is HHV-6 reactivation, particularly in specific populations:
High-Risk Groups for Reactivation 3, 4:
- Hematopoietic stem cell transplant recipients
- Solid organ transplant recipients
- Patients with hematologic malignancies
- HIV/AIDS patients
- Those on immunomodulating therapy (natalizumab, rituximab)
Clinical Manifestations of Reactivation 4, 5:
- Encephalitis/encephalopathy (most serious complication)
- Bone marrow suppression
- Graft-versus-host disease
- Transplant failure
Diagnostic Considerations
Important caveat: CSF PCR for HHV-6 has a high false-positive rate in adults. The guideline notes a positive predictive value of only 30% in healthy adults, with a 95% detection rate even in asymptomatic individuals 4. This is partly due to chromosomally integrated HHV-6 (CIHHV-6), present in ~1% of the population, which causes persistently detectable viral DNA without active infection 3.
Clinical Bottom Line
In immunocompetent adults presenting with fever and rash, roseola should be included in the differential diagnosis, though it remains uncommon 2. The real clinical concern is HHV-6 reactivation in immunocompromised adults, where encephalitis represents a serious and potentially treatable complication requiring ganciclovir or foscarnet 4.